According to the Zhitong Finance App, Haohai Biotechnology (06826.HK) announced that on July 21, 2026, it spent approximately HK$1,254 million to repurchase 73,000 shares.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.